Exovita Biosciences is an early-stage biotech company developing exosome-based cancer therapeutics. The company's technology is based on research by Kristina Trujillo (Assistant Professor, UNM Health Sciences’ Department of Cell Biology and Physiology). Trujillo helped discover cancer-killing properties in exosomes (vesicles or fluid-filled packets, that the body forms for cells to communicate with each other). Exosomes have highly selective toxicity against the tumor cells. Exovita is supported by New Mexico Startup Factory, the University of New Mexico Health Sciences Center, STC.UNM, and Peacock Myers.
Primary Industry:
N/A
Exovita Biosciences is an early-stage biotech company developing exosome-based cancer therapeutics. The company's technology is based on research by Kristina Trujillo (Assistant Professor, UNM Health Sciences’ Department of Cell Biology and Physiology). Trujillo helped discover cancer-killing properties in exosomes (vesicles or fluid-filled packets, that the body forms for cells to communicate with each other). Exosomes have highly selective toxicity against the tumor cells. Exovita is supported by New Mexico Startup Factory, the University of New Mexico Health Sciences Center, STC.UNM, and Peacock Myers.
Transparency
All reviews within the past 12 months
Total Reviews
Direct
Invited
Write a review ✍🏼
Leave your review here
0.00
out of 5
Based on 0 Reviews
Consumer
The number of user on TrustFinance
0
Powered by TrustFinance
We use cookies
Our website uses cookies to improve your browsing experience and to help us understand how users interact with our site. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.